Olympus Stock

JPY1,722.00

2.68% today

Tokyo, Jul 17, 08:15 am CET

ISIN

JP3201200007

Symbol

7733

Index

Nikkei 225

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Olympus Stock price

JPY1,719.00

-255.00 12.92% 5Y

Tokyo, Closing price Thu, Jul 17 2025

+42.00 2.50%

ISIN

JP3201200007

Symbol

7733

Index

Nikkei 225

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

JPY1.9t

Enterprise Value

JPY1.8t

Net debt

positive

Cash

JPY254.8b

Shares outstanding

1.1b

Valuation (TTM | estimate)

P/E

16.0 | 14.7

P/S

1.9 | 1.8

EV/Sales

1.9 | 1.8

EV/FCF

14.7

P/B

2.5

Dividends

DPS

JPY18.00

Yield 1Y | 5Y

1.1% | 0.7%

Growth 1Y | 5Y

12.5% | 19.1%

Payout 1Y | 3Y

9.0% | 11.9%

Increased

6 Years

Financials (TTM | estimate)

Revenue

JPY997.3b | JPY1.0t

EBITDA

JPY228.5b | JPY234.0b

EBIT

JPY162.0b | -

Net Income

JPY117.9b | JPY128.9b

Free Cash Flow

JPY125.3b

Growth (TTM | estimate)

Revenue

6.5% | 4.8%

EBITDA

85.3% | 2.4%

EBIT

182.6% | -

Net Income

-51.4% | 9.4%

Free Cash Flow

662.7%

Financial Health

Equity Ratio

52.5%

Return on Equity

15.7%

ROCE

16.1%

ROIC

14.2%

Debt/Equity

0.3

EPS

JPY104.5

FCF per Share

JPY111.1

Short interest

Employees

29k

Rev per Employee

JPY34.6m

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Olympus Stock Analysis

Unlock Scores for Free

??

20 Analysts have issued a Olympus forecast:

12x Buy

60%

8x Hold

40%

More details on Analyst Estimates Including Price Targets

20 Analysts have issued a Olympus forecast:

Buy

60%

Hold

40%

Analyst Estimates with Stock Price Targets

Financial data from Olympus

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	997,332 997,332	7% 7% 100%
- Direct Costs	313,635 313,635	1% 1% 31%
Gross Profit	683,697 683,697	9% 9% 69%
- Selling and Administrative Expenses	495,654 495,654	5% 5% 50%
- Research and Development Expense	- -	- -
EBITDA	228,452 228,452	85% 85% 23%
- Depreciation and Amortization	66,456 66,456	1% 1% 7%
EBIT (Operating Income) EBIT	161,996 161,996	183% 183% 16%
Net Profit	117,855 117,855	51% 51% 12%

In millions JPY.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Head office	Japan
CEO	Yasuo Takeuchi
Employees	28,838
Founded	1919
Website	www.olympus.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now